Advicenne S.A. (EPA:ALDVI)
 1.728
 +0.084 (5.11%)
  Nov 3, 2025, 2:34 PM CET
Advicenne Revenue
Advicenne had revenue of 3.27M EUR in the half year ending June 30, 2025, with 91.89% growth. This brings the company's revenue in the last twelve months to 5.90M, down -5.38% year-over-year. In the year 2024, Advicenne had annual revenue of 5.27M, down -0.51%.
Revenue (ttm) 
 5.90M
Revenue Growth 
 -5.38%
P/S Ratio 
 4.09
Revenue / Employee 
 453.54K
Employees 
 13
Market Cap 
24.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 5.27M | -27.00K | -0.51% | 
| Dec 31, 2023 | 5.30M | 1.58M | 42.53% | 
| Dec 31, 2022 | 3.72M | -9.00K | -0.24% | 
| Dec 31, 2021 | 3.72M | 233.00K | 6.67% | 
| Dec 31, 2020 | 3.49M | 907.00K | 35.10% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Sanofi | 45.93B | 
| EssilorLuxottica Société anonyme | 27.24B | 
| Eurofins Scientific SE | 7.14B | 
| emeis Société anonyme | 5.77B | 
| Clariane SE | 5.31B | 
| bioMérieux | 4.12B | 
| Ipsen | 3.76B | 
| Sartorius Stedim Biotech | 2.95B |